Skip to main content

Table 2 Average daily energy, macronutrient, Vitamin D and mineral intake during r-hPRL or placebo administration

From: Short-term prolactin administration causes expressible galactorrhea but does not affect bone turnover: pilot data for a new lactation agent

 

Placebo

r-hPRL

 

Before treatment

After treatment

Before treatment

After treatment

Energy (kcal)

1963 ± 164

1929 ± 164

1670 ± 190

1606 ± 244

Fat (g)

65. ± 8.4

66.9 ± 6.7

58.3 ± 8.1

55.8 ± 11.4

Protein (g)

67.5 ± 7.5

71.8 ± 7.5

63.8 ± 7.1

62.9 ± 9.9

Carbohydrate (g)

283 ± 23

267 ± 25

225 ± 27

206 ± 33

Vitamin D (μg)

3.7 ± 0.9

4.1 ± 0.9

5.9 ± 3.8

2.9 ± 0.8

Calcium (mg)

849 ± 92

749 ± 113

1019 ± 162

1054 ± 210

Phosphorus (mg)

1166 ± 123

1131 ± 135

1093 ± 106

1029 ± 128

Sodium (mg)

3460 ± 436

3823 ± 497

2505 ± 222

2517 ± 328

  1. All results: mean ± SE